Home
Live Updates
Vanda Pharmaceuticals Reacts to U.S. Supreme Courts Denial of its Petition in HETLIOZ® ANDA Litigation : comparemela.com
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
WASHINGTON, April 22, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZĀ® Abbreviated New Drug...
Related Keywords
Washington ,
United States ,
Mihaelh Polymeropoulos ,
Kevin Moran ,
Jack Kelleher Dan Moore ,
Vanda Pharmaceuticals Inc ,
Apotex Inc ,
Prnewswire Vanda Pharmaceuticals Inc ,
Twitter ,
Teva Pharmaceuticals United States Inc ,
Supreme Court ,
Apotex Corp ,
Abbreviated New Drug Application ,
Teva Pharmaceuticals United States ,
Important Safety Information ,
Vice President ,
Chief Financial Officer ,
Jack Kelleher ,
Markets ,
comparemela.com © 2020. All Rights Reserved.